EVOLYBRI
Live / Registered — Registered (as of 07 Jan 2020)
What this means for you
Registered since 07 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79265323
- Registration number
- 5952506
- Mark type
- Stylized text
- Filed
- 25 Jun 2019
- Published for opposition
- 22 Oct 2019
- Registered
- 07 Jan 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; [ cardiovascular pharmaceuticals; ] dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use [ in hematology and ] in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; [ pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; [ pharmaceutical preparations for the prevention and treatment of hypertension; ] pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma * excluding pharmaceutical preparations in the field of cardiovascular, cardiac, vascular and hematological diseases and disorders *
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 07 Jan 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 07 Jan 2021 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 05 Jan 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 28 Apr 2020 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 28 Apr 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
- 23 Apr 2020 — ASSIGNED TO PARALEGAL
- 30 Mar 2020 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 27 Mar 2020 — LIMITATION OF GOODS RECEIVED FROM IB
- 25 Mar 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 20 Mar 2020 — NOTIFICATION PROCESSED BY IB
- 13 Mar 2020 — LIMITATION OF GOODS RECEIVED FROM IB
- 29 Feb 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Feb 2020 — FINAL DISPOSITION PROCESSED
- 06 Feb 2020 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 07 Jan 2020 — REGISTERED-PRINCIPAL REGISTER